US Regulators Reject Request to Clear Cheap Drug for Treatment of COVID-19

Contact Your Elected Officials
The Epoch Times Header

U.S. regulators have rejected a request to grant emergency authorization to a cheap drug for the treatment of COVID-19, drawing criticism from one of the doctors that asked for the clearance.

The Food and Drug Administration (FDA), in a 27-page memorandum explaining its decision, said that the benefit of fluvoxamine was โ€œnot persuasive when focusing on clinically meaningful outcomes such as proportion of patients experiencing hospitalizations or hospitalizations and deaths.โ€

A review of clinical trials that have examined fluvoxamine, a widely used antidepressant, against COVID-19 led to the conclusion that the data at this time are insufficient for emergency clearance, the FDA added.

Dr. David Boulware, who drew up the request because he believes more COVID-19 treatments are needed, said that the FDA erred because it used different criteria when analyzing fluvoxamine than when it analyzed drugs from major pharmaceutical companies, such as a pill from Pfizer called paxlovid.

Hospitalization was defined in the trials for those drugs as receiving over 24 hours of acute care, whether in a hospital or similar facility. But it analyzed hospitalization in the case of fluvoxamine only in hospitals, excluding similar facilities.

โ€œFDA should evaluate clinical trials using the same endpoint definitions for generic drugs as for big pharma. The deliberate creation of two-tiered system is inappropriate,โ€ Boulware, a professor of medicine at the University of Minnesota, said in a letter to Dr. Peter Stein, who is the director of the FDAโ€™s Office of New Drugs.

Asked for a comment on Boulwareโ€™s letter, an FDA spokesperson told The Epoch Times in an email that the agency after its review โ€œwas unable to reasonably conclude that fluvoxamine may be effective for the treatment of outpatient adults with COVID-19 to prevent severe disease progression and/or hospitalization.โ€

The COVID-19 Treatment Guidelines Panel, convened by the National Institutes of Health, says that it cannot recommend for or against fluvoxamine against COVID-19 due to โ€œinsufficient evidence.โ€

Supporters, though, note that some trials have shown efficacy against COVID-19.

Byย Zachary Stieber

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Understanding the freedom of speech difficulty UK ?

Freedom of speech in the UK, shaped by evolving laws, faces legal conflictsโ€”highlighted by Nigel Farageโ€™s recent U.S. Congress testimony.

US Supreme Court Asked to Rule on Whether Private Citizens Can Enforce Voting Rights Act

A lower court ruled earlier this year that only...

Judicial activism has run amok

Judge Charles Breyer blocked Trump's use of California's National Guard, citing the Posse Comitatus Act, sparking debate over presidential authority.

The SCO & BRICS Play Complementary Roles In Gradually Transforming Global Governance

SCO and BRICS will gradually shape global governance, not abruptly, due to diverse members and non-binding decisions slowing consensus.

Transitioning from Regulatory Sclerosis to Arbitrary State Capitalism

The Trump administration is moving from reducing the size and regulatory power of the federal government to the formation of State Capitalism.

Democrats Highlight August Organizing, Say They Want Bipartisan Deal to Avert Shutdown

Rep Hakeem Jeffries said during recess Democrats organized across the country and will seek a bipartisan spending bill as Congress with Sept. 30 deadline.

Judge Reverses Trump Adminโ€™s Harvard Funding Freeze

Federal judge blocked Trump adminโ€™s bid to freeze $2B in Harvard funding, ruling it violated the First Amendment in its anti-Semitism efforts.

Putin, Xi Hot Mic Moment on Organ Transplants Underscores Concerns Over Organ Harvesting in China

On Sept. 3, a hot mic caught China and Russiaโ€™s leaders discussing about organ transplants and living to 150 as they walked side by side.

Pfizer CEO Says Trump Should Receive Nobel Prize for Operation Warp Speed

Pfizerโ€™s CEO praised President Trump, saying he deserves a Nobel Peace Prize for Operation Warp Speed that sped COVID-19 vaccine delivery.

Trump to Host Polandโ€™s New President Nawrocki at the White House

President Donald Trump will host Polandโ€™s newly elected president, Karol Nawrocki, at the White House on Sept. 3.

Trump Announces Space Command Moving to Alabama

โ€œI am thrilled to report that the U.S. Space Command headquarters will move to beautiful Huntsville, Alabama,โ€ President Trump said.

Trump Takes Aim at Crime in Chicago After Dozens Shot Over Weekend

President Trump said that he will โ€œsoonโ€ take actions to deal with crime in Chicago, weeks after he sent National Guard troops to Washington, D.C.

Trump Says India Offered Zero Tariffs After Decades of โ€˜One-Sidedโ€™ Trade

President Trump said India offered to cut tariffs on U.S. goods to zero, calling it a long-overdue fix for decades of one-sided trade.
spot_img

Related Articles